Frontlight ResearchEarly access
Trial site
The Third People's Hospital of Zhenjiang
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Primary biliary cholangitis3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Hepatitis B2 trials
- Liver cirrhosis2 trials
- Phase
- Phase 35 trials
- Phase 23 trials
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Ausper Biopharma Co., Ltd.2 trials
- Boehringer Ingelheim2 trials
- Cascade Pharmaceuticals, Inc2 trials
- Gilead Sciences1 trial
- Healthgen Biotechnology Corp.1 trial
Running trials
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Active, not recruiting
Recruiting
Recruiting
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Active, not recruiting
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Primary biliary cholangitis2 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026